By harnessing cutting-edge medicinal chemistry, we can create next-generation small-molecule therapies designed for superior efficacy and patient outcomes.
Terremoto translates to ‘earthquake.’
A name that reflects our bold approach. At Terremoto Biosciences, we’re redefining what’s possible in small-molecule therapeutics. While traditional inhibitors have been limited by short durability, safety concerns, and narrow domain of applicability, we’re changing that. Grounded in deep disease biology and powered by cutting-edge medicinal chemistry, we design safe, effective oral medicines that don’t just aim to be best-in-class—they aim to set a new class standard.
An earth-shattering approach.
Novel covalency technologies are central to our drug discovery strategy—unlike earlier generation covalent compounds, our inhibitors are engineered for surgical precision, delivering unparalleled selectivity that enhances safety and efficacy for targets with historically narrow therapeutic windows. Leveraging covalency as a tool in hit-finding also broadens the range of drug targets we can pursue, unlocking new possibilities for small-molecule medicines.
Seeking the bold to join our mission.
With our bedrock foundation, Terremoto is cultivating a unique, inclusive culture of excellence. We’re looking for passionate drug-hunters and relentless innovators—who combine scientific creativity with unwavering drive—to join us in delivering transformative therapies to patients.
Nothing Found
Sorry, no posts matched your criteria